ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
121 hedge funds and large institutions have $106M invested in Acorda Therapeutics in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
68% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 44
Holders
121
Holding in Top 10
–
Calls
$665K
Puts
$633K
Top Buyers
| 1 | +$7.51M | |
| 2 | +$1.42M | |
| 3 | +$866K | |
| 4 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$857K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$816K |
Top Sellers
| 1 | -$7.96M | |
| 2 | -$6.41M | |
| 3 | -$2.29M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.54M |